OBJECTIVE: A goal of asthma management is to improve the patient's health-related quality of life (HRQL). However, it is unclear whether HRQL instruments can discriminate across asthma control measures. The objective of this study was to evaluate the validity of generic and condition-specific preference-based instruments, in terms of their ability to distinguish asthma control. METHODS: Asthma patients (n = 157) completed three generic preference-based instruments: the Health Utility Index Mark 3 (HUI-3), the EuroQol (EQ-5D), and the Short Form 6D (SF-6D) and two condition-specific questionnaires: the standardized Asthma Quality of Life Questionnaire (AQLQ(S)) and the Asthma Control Questionnaire (ACQ). The AQLQ(S) scores were converted into the condition-specific preference-based scores: the Asthma Quality of Life Utility Index (AQL-5D). RESULTS: The preference-based instruments were generally able to discriminate across control measures, such as ACQ scores and magnitude of asthma medication, but were not able to discriminate for self-reported control and severity levels. These instruments also correlated with most control measures (r = 0.32-0.37). Significant relationships between AQL-5D scores and all control variables were observed. CONCLUSIONS: Overall, the AQL-5D discriminated across all levels of asthma control. The HUI-3, the EQ-5D, and the SF-6D differentiated between the highest and lowest levels of control but could not discriminate between the moderate levels.
OBJECTIVE: A goal of asthma management is to improve the patient's health-related quality of life (HRQL). However, it is unclear whether HRQL instruments can discriminate across asthma control measures. The objective of this study was to evaluate the validity of generic and condition-specific preference-based instruments, in terms of their ability to distinguish asthma control. METHODS: Asthma patients (n = 157) completed three generic preference-based instruments: the Health Utility Index Mark 3 (HUI-3), the EuroQol (EQ-5D), and the Short Form 6D (SF-6D) and two condition-specific questionnaires: the standardized Asthma Quality of Life Questionnaire (AQLQ(S)) and the Asthma Control Questionnaire (ACQ). The AQLQ(S) scores were converted into the condition-specific preference-based scores: the Asthma Quality of Life Utility Index (AQL-5D). RESULTS: The preference-based instruments were generally able to discriminate across control measures, such as ACQ scores and magnitude of asthma medication, but were not able to discriminate for self-reported control and severity levels. These instruments also correlated with most control measures (r = 0.32-0.37). Significant relationships between AQL-5D scores and all control variables were observed. CONCLUSIONS: Overall, the AQL-5D discriminated across all levels of asthma control. The HUI-3, the EQ-5D, and the SF-6D differentiated between the highest and lowest levels of control but could not discriminate between the moderate levels.
Authors: Marilyn L Moy; Anne L Fuhlbrigge; Karen Blumenschein; Richard H Chapman; Alan J Zillich; Karen M Kuntz; A David Paltiel; Barrett T Kitch; Scott T Weiss; Peter J Neumann Journal: Ann Allergy Asthma Immunol Date: 2004-03 Impact factor: 6.347
Authors: Paul M O'Byrne; Hans Bisgaard; Philippe P Godard; Massimo Pistolesi; Mona Palmqvist; Yuanjue Zhu; Tommy Ekström; Eric D Bateman Journal: Am J Respir Crit Care Med Date: 2004-10-22 Impact factor: 21.405
Authors: Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen Journal: Am J Respir Crit Care Med Date: 2004-07-15 Impact factor: 21.405
Authors: Wenjia Chen; Larry D Lynd; J Mark FitzGerald; Carlo A Marra; Roxanne Rousseau; Mohsen Sadatsafavi Journal: Qual Life Res Date: 2015-06-03 Impact factor: 4.147
Authors: Sandra R Wilson; Cynthia S Rand; Michael D Cabana; Michael B Foggs; Jill S Halterman; Lynn Olson; William M Vollmer; Rosalind J Wright; Virginia Taggart Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: T A Kanters; W K Redekop; M E Kruijshaar; A T van der Ploeg; M P M H Rutten-van Mölken; L Hakkaart Journal: Qual Life Res Date: 2014-10-24 Impact factor: 4.147
Authors: Patrick W Sullivan; Vahram H Ghushchyan; Jonathan D Campbell; Gary Globe; Bruce Bender; David J Magid Journal: Qual Life Res Date: 2016-07-07 Impact factor: 4.147
Authors: Jean-Eric Tarride; Natasha Burke; Matthias Bischof; Robert B Hopkins; Linda Goeree; Kaitryn Campbell; Feng Xie; Daria O'Reilly; Ron Goeree Journal: Health Qual Life Outcomes Date: 2010-01-27 Impact factor: 3.186
Authors: Francisco-Javier Gonzalez-Barcala; Ramon de la Fuente-Cid; Mónica Tafalla; Javier Nuevo; Francisco Caamaño-Isorna Journal: Multidiscip Respir Med Date: 2012-10-02